SCHEMBL4739765

SCHEMBL4739765

Oc1ccccc1Cn1cc(-c2ccccc2)[nH]c1=S

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.46
KMT2A Q03164 8/20 0.46
KDM4E B2RXH2 8/20 0.46
MEN1 O00255 4/20 0.46
RECQL P46063 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
GAA P10253 8/20 0.42
MAPT P10636 7/20 0.42
MAPK1 P28482 3/20 0.42
MCL1 Q07820 2/20 0.42
GFER P55789 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
MPO P05164 1/20 0.40
NPC1 O15118 3/20 0.39
HPGD P15428 1/20 0.39
HDAC8 Q9BY41 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4738141 0.82 RAB9A (0.46) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL4736170 0.80 KMT2A (0.58) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL4737872 0.79 KMT2A (0.51) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL4735266 0.79 DBH (0.56) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL4735233 0.75 KMT2A (0.57) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL4786062 0.74 RAB9A (0.50) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL4739836 0.73 KMT2A (0.49) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL9372580 0.72 RAB9A (0.50) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL4739723 0.72 RAB9A (0.45) RAB9AKMT2AKDM4EMEN1RECQL
SCHEMBL4738830 0.70 KMT2A (0.61) RAB9AKMT2AKDM4EMEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008085008-A1 T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2008-07-17 WO claimed
WO-2008085008-A1 T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2008-07-17 WO disclosed
WO-2008085008-A1 T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2008-07-17 WO disclosed